Vimarsana
Biggest News Aggregation in the World

Page 46 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

Where Will CRISPR Therapeutics Be in 10 Years? - Vimarsana News

Where Will CRISPR Therapeutics Be in 10 Years?

The biotech is part of a revolution in gene-editing therapies.

Source: fool.com
Accelerating Rare disease Cures (ARC) Program Emerges as a Conduit for Empowering Rare Disease Stakeholders - Vimarsana News

Accelerating Rare disease Cures (ARC) Program Emerges as a Conduit for Empowering Rare Disease Stakeholders

The ARC Program strives to increase the number of treatments by promoting innovative scientific design, providing a deeper understanding of regulatory policies, and engaging with patients and their advocates, and other rare disease stakeholders.

Source: fda.gov
Study: Only 1 in 4 addiction treatment facilities caring for U.S. adolescents offer buprenorphine - Vimarsana News

Study: Only 1 in 4 addiction treatment facilities caring for U.S. adolescents offer buprenorphine

Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study.

Insurance Status Tied to Transfer for STEMI - Vimarsana News

Insurance Status Tied to Transfer for STEMI

Uninsured patients with ST-segment elevation myocardial infarction who presented to the ED were less likely to be transferred to another facility than their insured counterparts, a cohort study suggests.

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals - Vimarsana News

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals

A statewide pay-for-performance intervention based on a set of guidelines called Choosing Wisely reduced rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage points, from 43% to 25%, across two large Los Angeles safety net hospitals.